Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2018 11:04 ET | Source: Genmab A/S

Interim Report First Quarter 2018

May 8, 2018; Copenhagen, Denmark; Interim Report for the First Quarter of 2018 Highlights USD 432 million in net sales of DARZALEX® (daratumumab); resulting in royalty income of DKK...
May 07, 2018 18:36 ET | Source: Genmab A/S

Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma

Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple...
April 25, 2018 11:59 ET | Source: Genmab A/S

Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting

Media Release 11 industry sponsored abstracts regarding Genmab programs scheduled for presentation at ASCO Annual MeetingOne oral presentation, three poster discussion sessions and seven...
April 19, 2018 09:30 ET | Source: Genmab A/S

Genmab A/S has published its Articles of Association

Genmab A/S has published its Articles of Association dated April 10, 2018. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm Contact: Rachel...
April 19, 2018 09:30 ET | Source: Genmab A/S

Selskabsvedtægter for Genmab A/S

Selskabsvedtægter for Genmab A/S dateret den 10. april 2018 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs...
April 17, 2018 06:48 ET | Source: Genmab A/S

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018

Company Announcement Net sales of DARZALEX in the first quarter of 2018 totaled USD 432 millionGenmab will receive royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen,...
April 10, 2018 13:47 ET | Source: Genmab A/S

Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement Copenhagen, Denmark; April 10, 2018 – Following Genmab A/S’ (Nasdaq Copenhagen: GEN) Annual General Meeting held on April 10, 2018, the Company’s Board of Directors...
April 10, 2018 09:43 ET | Source: Genmab A/S

Passing of Genmab A/S’ Annual General Meeting

Company Announcement At Genmab A/S’ Annual General Meeting held today April 10, 2018 the Annual Report for 2017 was approvedDischarge was given to the Board of Directors and the Executive...
April 03, 2018 12:28 ET | Source: Genmab A/S

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement Copenhagen, Denmark; April 3, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 30,149 shares as a consequence of the exercise of...
March 08, 2018 02:26 ET | Source: Genmab A/S

Genmab A/S Summons Annual General Meeting

Company Announcement Genmab A/S to hold Annual General Meeting on April 10, 2018 Copenhagen, Denmark; March 8, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) summons the Annual...